ARCHIVES

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003

Clinical Trials Approved By NCI In November

December 28, 2001

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

Cancer Control Budget Still $4 Million Short

January 28, 1977